These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2743578)

  • 1. Correction of subclinical ascorbate deficiency in patients receiving dialysis: effects on plasma oxalate, serum cholesterol, and capillary fragility.
    Tomson CR; Channon SM; Parkinson IS; McArdle P; Qureshi M; Ward MK; Laker MF
    Clin Chim Acta; 1989 Apr; 180(3):255-64. PubMed ID: 2743578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
    Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
    Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of vitamin C intake on plasma oxalate in patients on regular haemodialysis.
    Rolton HA; McConnell KM; Modi KS; Macdougall AI
    Nephrol Dial Transplant; 1991; 6(6):440-3. PubMed ID: 1876286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients.
    Shah GM; Ross EA; Sabo A; Pichon M; Reynolds RD; Bhagavan H
    Am J Kidney Dis; 1992 Jul; 20(1):42-9. PubMed ID: 1621677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascorbate-induced hyperoxalaemia has no significant effect on lactate generation or erythrocyte 2,3,diphosphoglycerate in dialysis patients.
    Tomson CR; Channon SM; Ward MK; Laker MF
    Eur J Clin Invest; 1990 Aug; 20(4):411-5. PubMed ID: 2121500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma oxalate concentration, oxalate clearance and cardiac function in patients receiving haemodialysis.
    Tomson CR; Channon SM; Ward MK; Laker MF
    Nephrol Dial Transplant; 1989; 4(9):792-9. PubMed ID: 2516611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal.
    Costello JF; Sadovnic MJ; Cottington EM
    J Am Soc Nephrol; 1991 Jun; 1(12):1289-98. PubMed ID: 1912391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population.
    Singer R; Rhodes HC; Chin G; Kulkarni H; Ferrari P
    Nephrology (Carlton); 2008 Feb; 13(1):17-22. PubMed ID: 18199096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma oxalate in patients receiving continuous ambulatory peritoneal dialysis.
    Tomson CR; Channon SM; Parkinson IS; Owen JP; Ward MK; Simpson JM; Laker MF
    Nephrol Dial Transplant; 1988; 3(3):295-9. PubMed ID: 3140104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin C augments lymphocyte glutathione in subjects with ascorbate deficiency.
    Lenton KJ; Sané AT; Therriault H; Cantin AM; Payette H; Wagner JR
    Am J Clin Nutr; 2003 Jan; 77(1):189-95. PubMed ID: 12499341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pyridoxine supplementation on plasma oxalate concentrations in patients receiving dialysis.
    Tomson CR; Channon SM; Parkinson IS; Sheldon WS; Ward MK; Laker MK
    Eur J Clin Invest; 1989 Apr; 19(2):201-5. PubMed ID: 2499479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of megadoses of ascorbic acid on serum and urinary oxalate.
    Hatch M; Mulgrew S; Bourke E; Keogh B; Costello J
    Eur Urol; 1980; 6(3):166-9. PubMed ID: 7371664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxine.
    Morgan SH; Maher ER; Purkiss P; Watts RW; Curtis JR
    Nephrol Dial Transplant; 1988; 3(1):28-32. PubMed ID: 3132636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase.
    Kasidas GP; Rose GA
    Clin Chim Acta; 1986 Jan; 154(1):49-58. PubMed ID: 3943224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marginal Ascorbate Status (Hypovitaminosis C) Results in an Attenuated Response to Vitamin C Supplementation.
    Carr AC; Pullar JM; Bozonet SM; Vissers MC
    Nutrients; 2016 Jun; 8(6):. PubMed ID: 27271663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Levels of serum ascorbate and its metabolites in hemodialysis patients].
    Hirano H; Tone Y; Otani H; Oya M; Kimura K; Saika Y; Fujii R; Mune M; Ichinose M; Yukawa S
    Nihon Jinzo Gakkai Shi; 2004 Jul; 46(5):426-33. PubMed ID: 15446598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No effect on serum lipids by moderate and high doses of vitamin C in elderly subjects with low plasma ascorbic acid levels.
    Aro A; Kyllästinen M; Kostiainen E; Gref CG; Elfving S; Uusitalo U
    Ann Nutr Metab; 1988; 32(3):133-7. PubMed ID: 3190163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated blood histamine caused by vaccinations and Vitamin C deficiency may mimic the shaken baby syndrome.
    Clemetson CA
    Med Hypotheses; 2004; 62(4):533-6. PubMed ID: 15050101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of high dose vitamin C on urinary oxalate levels.
    Wandzilak TR; D'Andre SD; Davis PA; Williams HE
    J Urol; 1994 Apr; 151(4):834-7. PubMed ID: 8126804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.